Chiral Technologies Acquiring Diffinity Genomics | GenomeWeb

NEW YORK (GenomeWeb) – Chiral Technologies today announced it is acquiring DNA purification firm Diffinity Genomics for an undisclosed amount. 

Upon completion of the deal, Diffinity will become a business unit of Chiral, which is part of Daicel. Diffinity CEO Joseph Marasco will leave the company in order to pursue other interests, Chiral said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.